The Board of Directors of Enwei Pharmaceutical Co., Ltd. has authorized a buyback plan on October 20, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.16 CNY | -5.02% |
|
-11.18% | -20.99% |
05-14 | Enwei Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023 | CI |
04-21 | Enwei Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-20.99% | 298M | |
+55.19% | 815B | |
+46.54% | 654B | |
-6.09% | 354B | |
+21.92% | 337B | |
+19.34% | 247B | |
+3.97% | 229B | |
+14.12% | 219B | |
+10.86% | 171B | |
-2.78% | 159B |
- Stock Market
- Equities
- 301331 Stock
- News Enwei Pharmaceutical Co., Ltd.
- Enwei Pharmaceutical Co., Ltd. authorizes a Buyback Plan.